PulteGroup Increases Quarterly Cash Dividend by 7% to $0.15 Per Share

ATLANTA--(BUSINESS WIRE)-- PulteGroup, Inc. (NYSE: PHM) announced today that its Board of Directors voted to approve a 7% increase in the Company’s quarterly cash dividend to $0.15 per common share. The increase will be effective with the Company’s next scheduled dividend, which is payable January 4, 2022, to shareholders of record at the close of business on December 15, 2021.

“This is the fourth consecutive year in which PulteGroup has raised its dividend and brings the total per-share increase during this period to 67%,” said PulteGroup President and CEO, Ryan Marshall. “The strong cash flows of the business have not only allowed us to again raise our dividend, but also fund year-over-year increases in both land investment and share repurchase activities in 2021.”

About PulteGroup

PulteGroup, Inc. (NYSE: PHM), based in Atlanta, Georgia, is one of America’s largest homebuilding companies with operations in more than 40 markets throughout the country. Through its brand portfolio that includes Centex, Pulte Homes, Del Webb, DiVosta Homes, American West and John Wieland Homes and Neighborhoods, the company is one of the industry’s most versatile homebuilders able to meet the needs of multiple buyer groups and respond to changing consumer demand. PulteGroup’s purpose is building incredible places where people can live their dreams.

For more information about PulteGroup, Inc. and PulteGroup’s brands, go to pultegroup.com; www.pulte.com; www.centex.com; www.delwebb.com; www.divosta.com; www.jwhomes.com; and www.americanwesthomes.com. Follow PulteGroup, Inc. on Twitter: @PulteGroupNews

View source version on businesswire.com: https://www.businesswire.com/news/home/20211201006207/en/

Investors: Jim Zeumer
(404) 978-6434
[email protected]

Source: PulteGroup, Inc.

You May Also Be Interested In

• Pampers & 4Kira4Moms Host Los Angeles Community Baby Shower Supporting 30 Deserving Parents
• ITM and Lumara Bio Announce Real-World Re-treatment Data and Dosimetry Results from COMPETE for ¹⁷⁷Luedotreotide (ITM-11) in GEP-NETs at ASTRO 2026
• Sui Price Prediction: SUI Rebounds Above $1.25 as Remittix Releases Its Revamped Investor Dashboard